Participants 73 130 6
overweight and obese subjects with cardiovascular disease
Participants 313 407 6
overweight and obese subjects receiving long-term sibutramine treatment with diet and exercise
Participants 631 726 7
9804 male and female subjects, aged 55 years or older, with a body mass index of 27-45 kg m
Participants 803 1002 3
ere required to have a history of cardiovascular disease and/or type 2 diabetes mellitus with at least one cardiovascular risk factor (hypertension, dyslipidemia, current smoking or diabetic nephropa
Participants 2224 2272 4
 be harmful in this obese elderly cardiovascular
